102/Vial Cyanocobalamin injection (Vitamin B12) is used to treat and prevent B12 deficiency caused by pernicious anemia, gastrointestinal disorders, or restrictive diets
It eliminates the most common dosing errors that researchers make when working with any reconstituted peptide solution
When adverse effects occurred, they were typically mild and transient, with the most common being mild to moderate headaches (similar frequency to placebo groups), minor injection site reactions (redness, slight swelling), and gastrointestinal effects at higher oral doses (nausea, diarrhea)
The FDA added it to injectable semaglutide in January 2025, and it climbs the dose axis like everything else. Burning or tingling skin tracks the dose, not the weight lost, and an active-comparator study put the risk about twice that of another weight-loss drug. The mechanism remains unsettled